150 related articles for article (PubMed ID: 30381389)
1. Hepatic abnormalities identified by staging MRI and accuracy of MRI of patients with uveal melanoma.
Francis JH; Catalanotti F; Landa J; Barker CA; Shoushtari AN; Abramson DH
Br J Ophthalmol; 2019 Sep; 103(9):1266-1271. PubMed ID: 30381389
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
[TBL] [Abstract][Full Text] [Related]
3. Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma.
Feinstein EG; Marr BP; Winston CB; Abramson DH
Arch Ophthalmol; 2010 Mar; 128(3):319-23. PubMed ID: 20212202
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Ultrasonography Compared With Computed Tomography and Magnetic Resonance Imaging at Diagnosis of Metastatic Uveal Melanoma.
Rantala ES; Peltola E; Helminen H; Hernberg M; Kivelä TT
Am J Ophthalmol; 2020 Aug; 216():156-164. PubMed ID: 32278769
[TBL] [Abstract][Full Text] [Related]
5. Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma.
Patel M; Winston CB; Marr BP; Carvajal RD; Schwartz GK; Wolchok J; Busam K; Abramson DH
Arch Ophthalmol; 2011 Dec; 129(12):1576-82. PubMed ID: 22159677
[TBL] [Abstract][Full Text] [Related]
6. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).
Servois V; Mariani P; Malhaire C; Petras S; Piperno-Neumann S; Plancher C; Levy-Gabriel C; Lumbroso-le Rouic L; Desjardins L; Salmon RJ
Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851
[TBL] [Abstract][Full Text] [Related]
7. Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver.
Liao A; Mittal P; Lawson DH; Yang JJ; Szalai E; Grossniklaus HE
Ophthalmology; 2018 Apr; 125(4):597-605. PubMed ID: 29122287
[TBL] [Abstract][Full Text] [Related]
8. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
[TBL] [Abstract][Full Text] [Related]
9. MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients.
Marshall E; Romaniuk C; Ghaneh P; Wong H; McKay M; Chopra M; Coupland SE; Damato BE
Br J Ophthalmol; 2013 Feb; 97(2):159-63. PubMed ID: 23159448
[TBL] [Abstract][Full Text] [Related]
10. The Liverpool uveal melanoma liver metastases pathway: outcome following liver resection.
Gomez D; Wetherill C; Cheong J; Jones L; Marshall E; Damato B; Coupland SE; Ghaneh P; Poston GJ; Malik HZ; Fenwick SW
J Surg Oncol; 2014 May; 109(6):542-7. PubMed ID: 24357463
[TBL] [Abstract][Full Text] [Related]
11. Risk-stratified systemic surveillance in uveal melanoma.
Davanzo JM; Binkley EM; Bena JF; Singh AD
Br J Ophthalmol; 2019 Dec; 103(12):1868-1871. PubMed ID: 30705044
[TBL] [Abstract][Full Text] [Related]
12. Liver function tests in metastatic uveal melanoma.
Kaiserman I; Amer R; Pe'er J
Am J Ophthalmol; 2004 Feb; 137(2):236-43. PubMed ID: 14962411
[TBL] [Abstract][Full Text] [Related]
13. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
[TBL] [Abstract][Full Text] [Related]
14. First experience on laparoscopic near-infrared fluorescence imaging of hepatic uveal melanoma metastases using indocyanine green.
Tummers QR; Verbeek FP; Prevoo HA; Braat AE; Baeten CI; Frangioni JV; van de Velde CJ; Vahrmeijer AL
Surg Innov; 2015 Feb; 22(1):20-5. PubMed ID: 24902685
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of liver metastases from uveal melanoma.
Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
[TBL] [Abstract][Full Text] [Related]
16. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
[TBL] [Abstract][Full Text] [Related]
17. UVEAL MELANOMA PRESENTING AS HEPATIC METASTASIS IN A PATIENT WITH OCULODERMAL MELANOCYTOSIS.
Evans WI; Wilson MW; Bahrami A; Pappo AS; Hoehn ME
Retin Cases Brief Rep; 2023 Jul; 17(4):403-405. PubMed ID: 37364199
[TBL] [Abstract][Full Text] [Related]
18. Treatment of liver metastases from uveal melanoma.
Rivoire M; Kodjikian L; Baldo S; Kaemmerlen P; Négrier S; Grange JD
Ann Surg Oncol; 2005 Jun; 12(6):422-8. PubMed ID: 15886904
[TBL] [Abstract][Full Text] [Related]
19. Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers.
Cohen VML; Pavlidou E; DaCosta J; Arora AK; Szyszko T; Sagoo MS; Szlosarek P
Middle East Afr J Ophthalmol; 2018; 25(2):91-95. PubMed ID: 30122854
[TBL] [Abstract][Full Text] [Related]
20. Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.
Luke JJ; Callahan MK; Postow MA; Romano E; Ramaiya N; Bluth M; Giobbie-Hurder A; Lawrence DP; Ibrahim N; Ott PA; Flaherty KT; Sullivan RJ; Harding JJ; D'Angelo S; Dickson M; Schwartz GK; Chapman PB; Wolchok JD; Hodi FS; Carvajal RD
Cancer; 2013 Oct; 119(20):3687-95. PubMed ID: 23913718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
